NOTICE OF ALLOWANCE - ISSUED
issued
on 04 Jun 2024
Last Applicant/ Owned by
17F., No. 3, Yuanqu St., Nangang Dist.,
Taipei City
TW
115603
Serial Number
97830057 filed on 09th Mar 2023
Registration Number
N/A
Correspondent Address
Joseph A. Bruce
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
APEXNK
Biological research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Research and development in the pharmaceutical and biotechnology fields; Medical research services; Medical research and development in the field of cancer immunotherapy; Research and developm Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Biological research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Research and development in the pharmaceutical and biotechnology fields; Medical research services; Medical research and development in the field of cancer immunotherapy; Research and development of new products for others; Technological research in the field of cancer immunotherapy; Conducting technical project studies in the nature of scientific feasibility studies; Technical writing for others; Scientific laboratory services; Scientific research; Technological consultancy services in the field of cancer immunotherapy; Scientific and technological research relating to cancer immunotherapy; Culturing of cells for others for scientific research purposes; New product design services; Packaging design; Graphic design services; Custom design of prototypes; Graphic design of logos; Quality control of goods and services; Product quality testing services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Immunostimulants; Pre-filled cell-based medicinal products, namely, medicinal products for aging, oncology and autoimmune disease; Biological tissue cultures for medical purposes; Anti-cancer preparations; Medicines for the treatment of cancer; Active pharmaceutical ingredient for western medicine, namely, pharmaceutical agents for aging, oncology and autoimmune disease; Anti-cancer agents; Antivirals; Biological preparations for the treatment of cancer; Biocides; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer treatment; Blood for medical purposes; Adjuvants for medical purposes; Albuminous preparations for medical purposes; Pharmaceuticals, namely, immunotherapy being immunostimulators; Pharmaceutical preparations for the treatment of cancer; Stem cells for medical purposes; Reagents for medical use; Diagnostic reagents for medical use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97830057
Mark Type
No Service Mark
Attorney Docket Number
No API-TA359
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 21st Nov 2024 | SOU TEAS EXTENSION RECEIVED |
| 21st Aug 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 21st Aug 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 21st Aug 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 04th Jun 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 02th Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 02th Apr 2024 | PUBLISHED FOR OPPOSITION |
| 13th Mar 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 28th Feb 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 21st Feb 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |